These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16900016)
21. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials. Khush KK; Waters DD J Card Fail; 2006 Oct; 12(8):664-74. PubMed ID: 17045188 [TBL] [Abstract][Full Text] [Related]
22. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
24. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Chapman MJ; Sposito AC Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759 [TBL] [Abstract][Full Text] [Related]
25. Impact of obesity on the health status of heart failure patients. Conard MW; Haddock CK; Poston WS; Havranek E; McCullough P; Spertus J; J Card Fail; 2006 Dec; 12(9):700-6. PubMed ID: 17174231 [TBL] [Abstract][Full Text] [Related]
26. Update in prevention of atherosclerotic heart disease: management of major cardiovascular risk factors. Romero-Corral A; Somers VK; Korinek J; Sierra-Johnson J; Thomas RJ; Allison TG; Lopez-Jimenez F Rev Invest Clin; 2006; 58(3):237-44. PubMed ID: 16958300 [TBL] [Abstract][Full Text] [Related]
27. The challenges associated with current clinical trials for diastolic heart failure. Thohan V; Patel S Curr Opin Cardiol; 2009 May; 24(3):230-8. PubMed ID: 19318936 [TBL] [Abstract][Full Text] [Related]
28. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ; Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406 [No Abstract] [Full Text] [Related]
29. Role of exercise and metabolism in heart failure with normal ejection fraction. Marwick TH; Wong CY Prog Cardiovasc Dis; 2007; 49(4):263-74. PubMed ID: 17185114 [TBL] [Abstract][Full Text] [Related]
30. The Metabolic Syndrome - a global challenge for prevention. Schwarz PE; Reimann M; Li J; Bergmann A; Licinio J; Wong ML; Bornstein SR Horm Metab Res; 2007 Nov; 39(11):777-80. PubMed ID: 17992630 [TBL] [Abstract][Full Text] [Related]
31. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. Selwyn AP Am J Cardiol; 2007 Dec; 100(12A):33P-37P. PubMed ID: 18154745 [TBL] [Abstract][Full Text] [Related]
32. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Ren J; Kelley RO Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173 [TBL] [Abstract][Full Text] [Related]
33. Adipokines in diabetes and cardiovascular diseases. Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155 [TBL] [Abstract][Full Text] [Related]
34. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Makkar KM; Sanoski CA; Spinler SA Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795 [TBL] [Abstract][Full Text] [Related]
36. [Obesity and hypertension]. Verdecchia P; Trimarco B G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751 [TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Bugger H; Abel ED Clin Sci (Lond); 2008 Feb; 114(3):195-210. PubMed ID: 18184113 [TBL] [Abstract][Full Text] [Related]
38. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Correia ML; Rahmouni K Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484 [TBL] [Abstract][Full Text] [Related]